DENVER - The leadership of the IASLC is pleased to see the European Parliament’s decision on a new European Tobacco Products Directive and hopes to see swift adoption of the text by the Council of Ministers.
Technique Offers Benefit over Currently Available Methods
DENVER – Researchers have developed a novel technique for detecting ALK rearrangements in non-small cell lung cancers (NSCLCs) that is more sensitive and easier to perform than currently available techniques.
DENVER –The findings of a recent study indicate that routine testing with both fluorescent in situ hybridization (FISH) and immunohistochemistry (IHC) may enhance the detection of ALK-positive non-small cell lung cancer (NSCLC).
DENVER – Adenocarcinoma histology, female sex, never-smoking status, and Asian ethnicity have been considered the most important factors associated with EGFR mutations in non-small cell lung cancer and response to EGFR inhibitors.